Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Health Ministry - Covid-19 Jabs Now Available to All 18+ Sudanese

10/14/2021 | 10:06am EST

The Director of Unified Immunisation at Sudan's federal Ministry of Health, Dr Ismail El Adani, has announced the availability of corona vaccines for people over 18 years. He called on all states of Sudan to provide vaccination opportunities for the mentioned age groups in order to reach the target number of citizens, which is 20 per cent, equivalent to eight million people. Nearly two million people have been vaccinated so far.

Sudan received the first shipment of Pfizer COVID-19 vaccines on October 6 of about half a million doses as part of a 1,274,130 donation from the USA through the Kovacs Platform. The Pfizer vaccine is the fourth COVID-19 vaccine to reach Sudan, while more than 1,700,000 people in Sudan have already been vaccinated against COVID-19 with AstraZeneca, Johnson & Johnson, or Sinapharm, Undersecretary of the Federal Ministry of Health Yusra Osman said on receiving the new shipment.

All requirements to keep and transport the Pfizer vaccine at a temperature of minus 70 to 80 degrees Celsius have been provided. Dr El Adani informed the press on the SUNA platform on Wednesday that people can start receiving the Pfizer vaccine next Sunday in Khartoum as a first phase.

The federal Ministry of Health announced the registration of 10 COVID-19 deaths on Tuesday, and 66 new infections with the coronavirus, with 544 active cases so far in the country.

The ministry said in its daily epidemiological report on Wednesday that Khartoum recorded 44 new cases, River Nile state 10 new cases, Northern State nine new cases, and one case in each of Kassala and West Kordofan, and another new case was registered in Khartoum, in the private laboratory of the International Hospital.

The report indicated that 10 deaths were recorded: three in Khartoum, three in Nile River state, two in Northern State, and one in El Gezira, and one in North Kordofan.

Copyright Radio Dabanga. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about PFIZER, INC.
04:39pWall Street ends higher in robust rebound from Omicron-driven rout
RE
02:25pDOJ, SEC Charge Former Immunomedics Finance Chief With Insider Trading
DJ
12:29pWhat COVID-19 vaccine and drug makers have to say about Omicron
RE
09:40aAmazon Web Services, Pfizer Collaborate to Improve New Medicine Development, Distributi..
MT
08:27aViiV - FORTY YEARS ON FROM THE START OF THE HIV EPIDEMIC, NEW DATA REVEALS PEOPLE LIVIN..
AQ
07:06aCovid-19 - Mobile Vaccination Teams Deployed to Weekly Markets, Inland Regions
AQ
05:10aHARVARD UNIVERSITY : Moderna edges out Pfizer vaccine in head-to-head comparison; Large-sc..
AQ
12/01UK Secures 114 Million Additional COVID-19 Shots From Pfizer/BioNTech, Moderna
MT
12/01Hexima Names New Chief Development Officer
MT
12/01U.S. administers 462.3 mln doses of COVID-19 vaccines - CDC
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 14,1x
Yield 2021 2,89%
Capitalization 307 B 307 B -
EV / Sales 2021 4,11x
EV / Sales 2022 3,87x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,68 $
Average target price 49,58 $
Spread / Average Target -9,34%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.48.55%306 912
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859
ABBVIE INC.8.18%204 915